MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

Home » Diabetes: Medtronic wins clearance for next-gen clinical continuous glucose monitor | Regulatory Roundup

Diabetes: Medtronic wins clearance for next-gen clinical continuous glucose monitor | Regulatory Roundup

By

Medtronic logo

Medtronic Inc. (NYSE:MDT) won FDA clearance for its next generation iPro2 Professional continuous glucose monitor.

The iPro2 Professional is a clinician-owned device that collects glucose data from a sensor inserted into a patient’s skin.

The device tracks the patient’s glucose levels for 3 days, collecting data as many as 288 times each day. The information may provide insight into how diet, medication and daily activities affect a patient’s glucose levels.

"I find it particularly helpful in identifying repeated glucose lows at night and glucose highs after meals," University Diabetes & Endocrine Consultants’ Dr. David Huffman said in prepared remarks. "I am one doctor in a busy office, but the advances with iPro2 will make Professional CGM accessible to more patients who need it. I see that as better medicine."

Professional CGM is ideal for patients with Type I or Type II diabetes who have are persistently unaware of extreme highs and lows in their glucose levels, according to a published consensus from the American Assn. of Clinical Endocrinologists. The clinician-led process was also recommended for pregnant women and youth with Type I diabetes.

Proper glucose control may help patients avoid complications associated with diabetes, including blindness, kidney failure, amputation, impotence and heart disease, according to a press release.

"CGM adoption is on the rise," Medtronic VP and general manager for the continuous glucose monitoring business Greg Meehan said in prepared remarks. "We believe the combination of improved reimbursement for both clinicians and patients, increased clinical evidence as seen in the Medtronic STAR 3 and JDRF trials, as well as ongoing product advancements, are moving CGM devices toward the standard of care for diabetes management."

Regulatory Roundup

  • Medtronic wins FDA nod for AdaptiveStim neurostimulator
    Medtronic announced approval of its AdaptiveStim with RestoreSensor neurostimulation system, the first and only chronic pain treatment that harnesses motion sensor technology found in smart phones and computer gaming systems to provide effective pain relief and convenience by automatically adapting stimulation levels.
    Read more

  • IntriCon lands 510(k) for cardiac diagnostic monitor
    IntriCon Corporation (NSDQ: IIN), developer of miniature and micro-miniature body-worn devices, received 510(k) clearance for its Sirona Event and Holter Recorder, the company’s second-generation cardiac diagnostic monitoring device, allowing physicians to monitor patient cardiac events remotely .
    Read more

  • SonoSite gets green light for Edge ultrasound system
    SonoSite Inc. (NSDQ:SONO) received FDA 510(k) clearance for its fifth-generation Edge ultrasound system.
    Read more

  • Staar Surgical wins CE mark for intraocular lens
    Staar Surgical Co., which designs, develops, manufactures and markets implantable lenses for the eye, received CE Mark approval in the European Union for its nanoFLEX Toric Collamer Single Piece intraocular lens.
    Read more

  • Vascular Designs lands regulatory wins for sideways perfusion catheter
    The IsoFlow Infusion Catheter, from Vascular Designs Inc.,  received CE Mark approval for use in Europe and Canada.
    Read more

  • Neovasc touts CE Mark for angina therapy
    Neovasc Inc. (NYSE: NVC) received CE mark approval for its Reducer product, which was developed to treat refractory angina.
    Read more

  • BSD Medical lands humanitarian device exemption
    BSD Medical Corp. (NSDQ:BSDM) obtained humanitarian device exemption marketing approval for the BSD-2000 Hyperthermia System.
    Read more

  • Dendreon Corp. wins reimbursement approval for Provenge
    Dendreon Corp. (NSDQ:DNDN) today announced the Centers for Medicare & Medicaid Services updated their coverage policy to now cover the infusion costs associated with the administration of Provenge.
    Read more

  • Retina Implant AG plans second human clinical trial
    Retina Implant AG announced that its scientific advisory board is in full support of beginning the multi-center phase of the company’s second human clinical trial for subretinal implants for retinitis pigmentosa patients.
    Read more

  • IsoRay wins State of Wash. approval for GliaSite
    IsoRay Inc. (AMEX: ISR) received final approval from the State of Washington Department of Health to manufacture its GliaSite radiation therapy system, a balloon catheter device used in the treatment of brain cancer.
    Read more

  • Canon touts clearance for radiography detectors
    Canon U.S.A. Inc. announced that the Canon CXDI-80C Wireless Digital Radiography Detector, along with the CXDI-501 Series DR Detectors, received 510(k) clearance.
    Read more

  • CerMed wins CE Mark for CerMap
    CerMed International, an international women’s medical device company, announced that it received CE Mark approval for CerMap, its advanced Cervical Specimen Collection Device used in cervical cancer screening procedures.
    Read more

  • Translational Sciences wins FDA clearance for imaging software
    Translational Sciences Corporation received FDA 510(k) clearance for commercialization of its OncoTrac medical imaging software.
    Read more

  • Merz Aesthetics gets green light for wrinkle treatment
    Merz Aesthetics today announced that the FDA cleared the Belotero Balance device for the correction of moderate-to-severe facial wrinkles and folds.

    Read more

    • In case you missed it

    RSS From Medical Design & Outsourcing

    • Medtronic CFO offers supply chain update as medical device industry concerns mount
      Medtronic (NYSE:MDT) was among the participants in a White House semiconductor summit last week to address the continuing global shortage of electronic chips. Still, CFO Karen Parkhill says the world’s largest medical device manufacturer is not in the same dire straits as chip buyers in other industries. Medtronic’s supply chain is “holding up OK, but… […]
    • SeaSpine warns of COVID-19 hit to surgical revenue
      SeaSpine Holdings (NSDQ:SPNE) is the latest medical device maker warning that the SARS-CoV-2 Delta variant wave is hurting its business. Carlsbad, California–based SeaSpine filed an update for investors with the Securities and Exchange Commission on Friday, citing “ongoing uncertainty regarding the duration and severity of COVID-19 and/or staffing shortages on spine surgery procedure volumes throughout… […]
    • Women may have more adverse events with left atrial appendage occlusion devices than men
      Women appear more likely than men to experience adverse events or lengthened hospital stays from left atrial appendage occlusion (LAAO) devices, the FDA announced today. In a letter to health care providers, the FDA said researchers have yet to determine the reason for the difference — and that it is working with device makers to… […]
    • A closer look at a microrobot that could treat a rare brain malformation
      Los Angeles–based startup Bionaut Labs emerged from stealth mode earlier this year to announce its intent to use drug-filled microrobots to treat certain cancers. The company has now secured a humanitarian use device designation from FDA to use a microrobot known as BNL-201 to treat Dandy-Walker syndrome, a rare brain malformation. In 1914, neurosurgeon Walter… […]
    • Heraeus buys Mo-Sci and ETS Technology Holdings
      The Heraeus Group has a deal to acquire Mo-Sci Corp. and ETS Technology Holdings, the Germany-based conglomerate announced this week. Mo-Sci is a supplier of glass microspheres, fibers and powders for medical devices, while ETS is the developer of bioactive glass fiber wound care product Mirragen, an FDA-cleared resorbable synthetic skin substitute. The companies —… […]
    • Medical Alley appoints new CEO
      The Medical Alley Association announced today that it appointed Roberta Dressen as its new president and CEO. Dressen takes over the position previously held by Shaye Mandle since 2014 before he announced his departure for the Biotechnology Innovation Organization (BIO) in February. Steffen Hovard served as interim CEO in the time since then. Get the full… […]
    • Westfall Technik names Mark Gomulka as CEO
      Westfall Technik’s board of directors has nominated Mark Gomulka to lead the company. Gomulka joined the Las Vegas–based plastics manufacturer as SVP in January 2020. Before that, he led Flex’s medical and precision plastics operations for five years and earlier spent 15 years at Nypro in various global operational and leadership roles. In those positions… […]
    • The MedTech Conference by AdvaMed to be a mixture of in-person and virtual
      To hold an event or not to hold a live event. Medtech trade association AdvaMed chose both for The Medtech Conference, which takes place next week. The September 27–30 conference includes a mixture of virtual presentations and in-person events in Washington, D.C., and Minneapolis. AdvaMed CEO Scott Whitaker mentioned several conference agenda highlights during a… […]
    • Varta launches online battery monitoring feature
      Battery maker Varta has launched a cloud computing feature to let customers remotely monitor battery charging, health and the temperature of the battery management system. While Varta makes microbatteries for medical devices such as hearing aids, the new online monitoring dashboard is meant for its “Easy Block” and “Easy Blade” modular smart batteries. The smart… […]
    • Bionaut Labs wins humanitarian use device designation to treat rare pediatric brain disorder
      Microrobotics startup Bionaut Labs has announced that FDA has granted a humanitarian use device designation for the device known as BNL-201 to treat Dandy-Walker syndrome, a congenital brain malformation affecting the cerebellum. According to the National Organization for Rare Disorders, the syndrome affects one out of every 25,000 to 35,000 live births. There are currently… […]
    • Integer plans $30 million innovation and manufacturing facility in Galway
      Integer Holdings Corp. (NYSE: ITGR) plans to build a medical device innovation and manufacturing facility in the Parkmore East area of Galway, Ireland. Plano, Texas–based Integer said the initial phase of the project will total 60,000 square feet and a $30 million investment over the coming years, with construction scheduled from 2022 to late 2023… […]

    Leave a Reply